Holen Sie sich die Stockscreener-App
0.6357
26.24%
-0.2262
Handel nachbörslich:
.61
-0.0257
-4.04%
Schlusskurs vom Vortag:
$0.8619
Offen:
$1.12
24-Stunden-Volumen:
56.87M
Relative Volume:
22.27
Marktkapitalisierung:
$3.35M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.00654
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-38.88%
1M Leistung:
-75.26%
6M Leistung:
-92.81%
1J Leistung:
-97.64%
1-Tages-Spanne:
$0.6036
$1.35
1-Wochen-Bereich:
$0.6036
$1.35
52-Wochen-Spanne:
$0.6036
$51.06
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
0.6357 | 3.35M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus
Aptevo Therapeutics announces $2 million stock offering - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan
Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com
How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com
Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus
Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa
APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia
Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Aptevo Secures Fresh $2.1M Capital: What This Means for Clinical Pipeline - Stock Titan
SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
Aptevo (APVO) Sees Significant Market Rally After Equity Offering - Stocks Telegraph
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise - MarketScreener
Aptevo Therapeutics (APVO) Announces $2.1 Million Securities Off - GuruFocus
Aptevo Therapeutics announces registered direct offering and warrants sale - Investing.com
Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering - TipRanks
Aptevo Raises Fresh Capital: $2.1M Direct Offering Plus Warrant Restructuring - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
APVO stock plunges to 52-week low, touches $0.99 By Investing.com - Investing.com India
APVO stock plunges to 52-week low, touches $0.99 - Investing.com
Virtu Financial LLC Has $93,000 Stake in Aptevo Therapeutics Inc. (NASDAQ:APVO) - Defense World
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Growth in Short Interest - Defense World
APVO stock plunges to 52-week low, touches $2.32 - Investing.com India
APVO stock plunges to 52-week low, touches $2.32 By Investing.com - Investing.com UK
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment - Benzinga
Aptevo Therapeutics Reports 2 More Remissions in AML Trial -March 20, 2025 at 09:35 am EDT - Marketscreener.com
Aptevo Therapeutics Achieves Remission Success in AML Trial - TipRanks
Aptevo reports two additional AML patients achieve remission in RAINIER trial - TipRanks
Breakthrough: New AML Drug Shows 90% Success Rate, Outperforming Standard Therapy by 24% - StockTitan
Aptevo Therapeutics advances cancer antibody APVO603 in preclinical phase - Investing.com
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy - ACCESS Newswire
Breakthrough Cancer Drug APVO603 Targets Two Immune Pathways to Fight Solid Tumors - Stock Titan
Aptevo Therapeutics (NASDAQ:APVO) Raised to Sell at StockNews.com - Defense World
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Increase in Short Interest - Defense World
APVO stock plunges to 52-week low of $2.48 amid steep annual decline - Investing.com Australia
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):